| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |